ACAT1/SOAT1 maintains adipogenic ability in preadipocytes by regulating cholesterol homeostasis

Qing Liu, Xiaolin Wu, Wei Duan, Xiaohan Pan, Martin Wabitsch, Ming Lu, Jing Li, Li‐Hao Huang, Zhangsen Zhou, Yuyan ZhuJournal of Lipid Research 2024 · DOI

TL;DR

This study reveals that ACAT1, an enzyme crucial for cholesterol esterification, plays a vital role in maintaining the ability of preadipocytes to differentiate into mature fat cells. By regulating cholesterol distribution, particularly at the plasma membrane, ACAT1 is essential for activating key adipogenic pathways, highlighting its importance in fat tissue expansion and potentially obesity.

What Problem Does This Paper Address?

Obesity is a major health concern, and understanding how fat cells (adipocytes) develop and expand is crucial. Adipogenesis, the process by which preadipocytes mature into adipocytes, is central to this. While cholesterol homeostasis is known to be critical for adipocyte function, the specific role of cholesterol esterification in this process has been underexplored. Acyl-CoA:cholesterol acyltransferase 1 (ACAT1) is the primary enzyme responsible for esterifying cholesterol into cholesteryl esters. Previous research hinted at ACAT1's involvement in adipogenesis, but the precise mechanisms remained unclear. This paper aims to elucidate how ACAT1 mediates adipogenesis by investigating its dominant role in white adipose tissue and its impact on cholesterol metabolism and key adipogenic signaling pathways.

Methods

The researchers employed a multi-pronged approach to investigate ACAT1's role:

  • Genetic Manipulation: They used both knockout (global ACAT1 KO mice) and knockdown (shRNA in 3T3-L1 cells) strategies to reduce ACAT1 levels. They also used lentivirus and adenovirus to overexpress functional or catalytically dead ACAT1.
  • Cell Culture Models: Murine 3T3-L1 preadipocytes and human SGBS preadipocytes were used for in vitro studies. Stromal vascular fraction (SVF) from mouse adipose tissue was also isolated and differentiated.
  • Biochemical Assays: Cholesterol levels (total, free, and esterified) were measured using enzymatic assays. Glucose uptake was assessed using a 2-deoxyglucose assay.
  • Molecular Biology Techniques: RNA sequencing (RNA-seq) was performed to identify differentially expressed genes. Quantitative PCR (qPCR) was used to measure mRNA levels of specific genes. Western blotting was employed to assess protein expression.
  • Imaging Techniques: Oil Red O staining was used to quantify lipid accumulation in adipocytes. Immunofluorescence microscopy was utilized to visualize cholesterol distribution within cells.
  • Animal Models: Lean and diet-induced obese (DIO) mice, as well as global ACAT1 knockout mice, were used to study ACAT1's role in vivo.

Datasets

The study utilized RNA sequencing data from shCTRL and shACAT1 3T3-L1 adipocytes at different time points during differentiation. This data was deposited in the NCBI's Sequence Read Archive (BioProject ID: PRJNA1061348).

Key Insights and Ideas

  • ACAT1 is the Dominant Player: The study firmly establishes ACAT1 as the primary ACAT isoform in white adipose tissue of both humans and mice, with ACAT2 playing a minimal role.
  • Cholesterol Esterification Fuels Adipogenesis: ACAT1's ability to esterify cholesterol is not just for storage but is actively required for preadipocytes to successfully differentiate into mature adipocytes.
  • Plasma Membrane Cholesterol Matters: ACAT1 deficiency leads to altered cholesterol distribution, specifically reducing plasma membrane (PM) cholesterol. This reduction impairs the cell's ability to respond to adipogenic signals.
  • PPARγ is a Key Downstream Target: The impaired adipogenesis in ACAT1-deficient cells is largely mediated by the attenuation of PPARγ, a master regulator of adipogenesis. Restoring cholesterol levels or supplementing with PPARγ agonists rescues this defect.
  • SREBP2 Pathway is Affected: ACAT1 deficiency impacts cholesterol uptake by downregulating SREBP2-mediated gene expression, contributing to lower intracellular and PM cholesterol levels.
  • Enzymatic Function is Crucial: Overexpressing a catalytically inactive form of ACAT1 could not rescue the adipogenic defect, underscoring that ACAT1's enzymatic activity in cholesterol esterification is essential.

Key Results

  • Knocking out ACAT1 in mice significantly reduced fat mass.
  • ACAT1 deficiency inhibited adipogenesis in preadipocytes at an early stage, evidenced by reduced lipid accumulation and altered expression of adipogenic genes.
  • ACAT1 knockdown led to decreased plasma membrane cholesterol and increased intracellular free cholesterol.
  • Replenishing PM cholesterol with MβCD-coated cholesterol rescued adipogenic gene transcription (PPARγ, SREBP1c) in ACAT1-deficient cells.
  • Overexpression of functional ACAT1 rescued the adipogenic ability, lipid accumulation, and glucose uptake in ACAT1-deficient preadipocytes.

Limitations and Future Work

  • Compensatory Effects: The study acknowledges the potential for compensatory effects between ACAT1 and ACAT2, particularly in murine models, which might complicate interpretation.
  • In Vivo Complexity: While global ACAT1 knockout mice showed reduced WAT mass, the contribution of ACAT1 from non-preadipocytes cannot be entirely excluded. The authors suggest further studies using AdipoChaser mice to specifically investigate ACAT1's role in adipocytes in vivo.
  • Detailed Cholesterol Trafficking: The precise mechanisms of cholesterol trafficking between intracellular organelles in ACAT1-deficient cells remain to be fully elucidated. The authors suggest the need for more advanced biochemical and imaging techniques to investigate this further.
  • Nutrient-Gene Interaction: The study highlights the interplay between dietary oleic acid and cholesterol in regulating adipogenesis, suggesting this as a potential factor in explaining differing phenotypes in ACAT1 knockout models.
  • Therapeutic Potential: The findings suggest ACAT1 as a potential therapeutic target for obesity, but further research is needed to explore this avenue safely and effectively.

Summary updated

Abstract

Maintaining cholesterol homeostasis is critical for preserving adipocyte function during the progression of obesity. Despite this, the regulatory role of cholesterol esterification in governing adipocyte expandability has been understudied. Acyl-coenzyme A (CoA):cholesterol acyltransferase/Sterol O-acyltransferase 1 (ACAT1/SOAT1) is the dominant enzyme to synthesize cholesteryl ester in most tissues. Our previous study demonstrated that knockdown of either ACAT1 or ACAT2 impaired adipogenesis. However, the underlying mechanism of how ACAT1 mediates adipogenesis remains unclear. Here, we reported that ACAT1 is the dominant isoform in white adipose tissue of both humans and mice, and knocking out ACAT1 reduced fat mass in mice. Furthermore, ACAT1-deficiency inhibited the early stage of adipogenesis via attenuating PPARγ pathway. Mechanistically, ACAT1 deficiency inhibited SREBP2-mediated cholesterol uptake and thus reduced intracellular and plasma membrane cholesterol levels during adipogenesis. Replenishing cholesterol could rescue adipogenic master gene-Pparγ's-transcription in ACAT1-deficient cells during adipogenesis. Finally, overexpression of catalytically functional ACAT1, not the catalytic-dead ACAT1, rescued cholesterol levels and efficiently rescued the transcription of PPARγ as well as the adipogenesis in ACAT1-deficient preadipocytes. In summary, our study revealed the indispensable role of ACAT1 in adipogenesis via regulating intracellular cholesterol homeostasis.
BibTeX
@article{liu2024acat,
  author = {Qing Liu and Xiaolin Wu and Wei Duan and Xiaohan Pan and Martin Wabitsch and Ming Lu and Jing Li and Li‐Hao Huang and Zhangsen Zhou and Yuyan Zhu},
  title = {{ACAT1/SOAT1 maintains adipogenic ability in preadipocytes by regulating cholesterol homeostasis}},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100680},
}
Figure